CURIS, INC. Proceeds from Sale of Productive Assets
CURIS, INC. (CRIS) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2018-03-08
- CURIS, INC. proceeds from sale of productive assets for the quarter ending 2015-12-31 was $5.21K.
- CURIS, INC. proceeds from sale of productive assets for the quarter ending 2014-12-31 was -$750.00.
- CURIS, INC. proceeds from sale of productive assets for the quarter ending 2011-12-31 was $17.42K.
- CURIS, INC. proceeds from sale of productive assets for the quarter ending 2011-09-30 was $23.20K.
- CURIS, INC. proceeds from sale of productive assets for fiscal 2017 was $0.00.
- CURIS, INC. proceeds from sale of productive assets for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- CURIS, INC. proceeds from sale of productive assets for fiscal 2015 was $24.00K, a 2300.00% increase from fiscal 2014.
- CURIS, INC. proceeds from sale of productive assets for fiscal 2014 was $1.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month | Proceeds from Sale of Productive Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-08 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 | ||||
| 2015-12-31 | $5.21K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $24.00K 10-K · filed 2018-03-08 | $23.79K 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $18.79K 10-Q · filed 2015-11-09 | ||||
| 2014-12-31 | -$750.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.00K 10-K · filed 2017-03-09 | $1.75K 10-K · filed 2015-02-24 | ||
| 2014-09-30 | $1.75K 10-Q · filed 2015-11-09 | ||||
| 2011-12-31 | $17.42K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $40.62K derived: sum of 2 quarters · filed 2014-03-13 | $45.84K derived: sum of 3 quarters · filed 2014-03-13 | $77.07K 10-K · filed 2014-03-13 | |
| 2011-09-30 | $23.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $28.43K derived: sum of 2 quarters · filed 2012-11-06 | $59.65K 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $5.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $36.45K 10-Q · filed 2012-08-09 | |||
| 2011-03-31 | $31.23K 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | $99.16K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |